Table 2 Baseline procedural characteristics of the patients
| Â | Before IPTW | After IPTW | ||||
|---|---|---|---|---|---|---|
Characteristics | SGLT2i group | DPP-4i group | p-value | SGLT2i group | DPP-4i group | p-value |
(n = 186) | (n = 593) | (n = 537) | (n = 532) | |||
Use of PCI | 184 (98.9) | 551 (92.9) | 0.001 | 537 (100.0) | 532 (100.0) | NA |
LMCA disease | 11 (5.9) | 38 (6.4) | 0.797 | 33 (6.1) | 33 (6.2) | 0.978 |
Multivessel CAD | 111 (59.7) | 353 (59.8) | 0.970 | 344 (64.1) | 320 (60.1) | 0.521 |
Use of transfemoral approach | 88 (47.8) | 248 (45.0) | 0.507 | 241 (44.9) | 246 (46.2) | 0.851 |
Use of GPIIb/IIIa inhibitor | 11 (6.0) | 46 (8.3) | 0.298 | 41 (7.7) | 43 (8.0) | 0.926 |
Use of thrombus aspiration | 12 (6.5) | 63 (11.4) | 0.057 | 79 (14.7) | 54 (10.2) | 0.460 |
Intracoronary imaging guidance (OCT or IVUS) | 63 (34.2) | 154 (27.9) | 0.105 | 151 (28.0) | 163 (30.7) | 0.627 |
Preprocedural TIMI flow grade 0-I | 81 (44.0) | 206 (35.6) | 0.041 | 175 (32.5) | 209 (39.2) | 0.240 |
ACC/AHA lesion characteristics B2/C | 151 (84.4) | 444 (84.4) | 0.987 | 471 (87.6) | 448 (84.2) | 0.344 |
Treatment strategies | Â | Â | 0.039 | Â | Â | 0.160 |
DES implantation | 178 (97.3) | 523 (94.9) | Â | 528 (98.2) | 512 (96.1) | Â |
BVS implantation | 1 (0.5) | 1 (0.2) | Â | 1 (0.2) | 0 (0.0) | Â |
Balloon angioplasty only | 3 (1.6) | 27 (4.9) | Â | 7 (1.3) | 20 (3.9) | Â |
Others | 1 (0.5) | 0 (0.0) | Â | 1 (0.3) | 0 (0.0) | Â |
Infarct-related artery | Â | Â | 0.306 | Â | Â | 0.614 |
LMCA or LAD | 98 (53.6) | 271 (49.2) | Â | 253 (47.1) | 268 (50.4) | Â |
LCX or RCA | 85 (46.4) | 280 (50.8) | Â | 284 (52.9) | 264 (49.6) | Â |